These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 26552190)

  • 21. The safety of drugs for OTC use: what evidence is required for an NSAID switch?
    MacDonald TM; Beard K; Bruppacher R; Hasford J; Lewis M; Logan RF; McNaughton D; Tubert-Bitter P; Van Ganse E; Moore N
    Pharmacoepidemiol Drug Saf; 2002; 11(7):577-84. PubMed ID: 12462134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interpretation of Technical Specifications for Revision of Safety Information in Marketed Chinese Patent Medicine Instructions].
    Zhang XM; Lin ZJ; Zhang B; Sa RN; Lyu JT; Wu H; Li YL; Xu HZ; Huang ZK; Guo YB; Su XF; Duan XJ
    Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(2):295-300. PubMed ID: 35178970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An overview of over the counter drugs in pregnancy and lactation.
    Das BP; Joshi M; Pant CR
    Kathmandu Univ Med J (KUMJ); 2006; 4(4):545-51. PubMed ID: 18603972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors influencing purchase of and counselling about prescription and OTC medicines at community pharmacies in Tallinn, Estonia.
    Villako P; Volmer D; Raal A
    Acta Pol Pharm; 2012; 69(2):335-40. PubMed ID: 22568049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-prescription medicines: current issues in Australian community pharmacy.
    Tan AC; Emmerton L
    Int J Pharm Pract; 2009 Aug; 17(4):207-13. PubMed ID: 20217945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A cross-sectional analysis of over-the-counter codeine use among an Australian sample of people who regularly inject drugs.
    Arora S; Roxburgh A; Bruno R; Nielsen S; Burns L
    Drug Alcohol Rev; 2013 Nov; 32(6):574-81. PubMed ID: 23751176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inappropriate use of over-the-counter (OTC) drugs and their administration].
    Moriya F
    Chudoku Kenkyu; 2012 Jun; 25(2):97-8. PubMed ID: 22774583
    [No Abstract]   [Full Text] [Related]  

  • 28. Monitoring safety of over the counter drugs. Over the counter medicines must be treated like all other medicines.
    Walmsley J; Marshall G
    BMJ; 2002 Feb; 324(7334):424-5. PubMed ID: 11855392
    [No Abstract]   [Full Text] [Related]  

  • 29. Lifestyle or life-saving medicines? A primary healthcare professional and consumer opinion survey on over-the-counter statins.
    Vamvakopoulos JE; Kountouri M; Marshall T; Greenfield SM
    Ann Pharmacother; 2008 Mar; 42(3):413-20. PubMed ID: 18303145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opportunities and challenges: over-the-counter codeine supply from the codeine consumer's perspective.
    Nielsen S; Cameron J; Pahoki S
    Int J Pharm Pract; 2013 Jun; 21(3):161-8. PubMed ID: 23419000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implications of over-the-counter proton pump inhibitors for patient counseling by pharmacists.
    Simonson W
    Am J Ther; 2013; 20(6):676-84. PubMed ID: 21642828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How the elderly and young adults differ in the decision making process of nonprescription medication purchases.
    Sansgiry SS; Cady PS
    Health Mark Q; 1996; 14(1):3-21. PubMed ID: 10163023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and patient awareness of selected potential drug interactions with self-medication.
    Indermitte J; Reber D; Beutler M; Bruppacher R; Hersberger KE
    J Clin Pharm Ther; 2007 Apr; 32(2):149-59. PubMed ID: 17381665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Post-marketing re-evaluation about usage and dosage of Chinese medicine based on human population pharmacokinetics].
    Jiang J; Xie Y
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2811-2. PubMed ID: 22292372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Reporting standards for expert consensus on clinical practice of Chinese patent medicines of China Association of Chinese Medicine].
    Mo M; Liao X; Zhang XX; Li B; Chen W; Zhao GZ; Guo YB
    Zhongguo Zhong Yao Za Zhi; 2019 Jun; 44(12):2644-2651. PubMed ID: 31359735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of over-the-counter insomnia complaints in Australian community pharmacies: a standardized patient study.
    Kashyap KC; Nissen LM; Smith SS; Kyle G
    Int J Pharm Pract; 2014 Apr; 22(2):125-34. PubMed ID: 23947610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Registration and review of Chinese patent drugs in Kunming and the compilation and revision of the
    Yang ZQ
    Zhonghua Yi Shi Za Zhi; 2017 Jul; 47(4):213-221. PubMed ID: 28954363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mifepristone (RU486) in Australian pharmacies: the ethical and practical challenges.
    Lee RY; Moles R; Chaar B
    Contraception; 2015 Jan; 91(1):25-30. PubMed ID: 25248673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Series of group standards of Technical Specifications for Revision of Safety Information in Marketed Chinese Patent Medicine Instructions].
    Zhang B; Zhang XM; Lin ZJ; Sa RN; Lyu JT; Wu H; Li YL; Xu HZ; Huang ZK; Guo YB; Su XF; Duan XJ
    Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(2):285-294. PubMed ID: 35178969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study on building index system of risk assessment of post-marketing Chinese patent medicine based on AHP-fuzzy neural network].
    Li Y; Xie Y; Fu Y
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2828-30. PubMed ID: 22292377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.